A new study confirms dapagliflozin helps patients with type 2 diabetes lose a few pounds in addition to improving their blood sugar levels.… What’s noteworthy about the study, say the researchers, is that dapagliflozin leads to loss of fat mass, with significant reductions in both abdominal visceral adipose tissue and …

We have seen that many of our diabetes patients also have hypertension and or elevated lipids and are often referred to as suffering from cardiometabolic syndrome. Over the past couple of months, Stan Schwartz, MD, FACP, has been educating us on the diagnosis and treatment of this syndrome. He finishes …

Last week I walked into the pharmacy and heard a call over the intercom, “Manager to deli, please.” I didn’t think anything of it until the manager called me back to the deli because one of his employees was lying on the floor with a glucose reading of 36mg/dl. We …

The new edition of this acclaimed title provides a practical guide to the risks and benefits of undertaking sport and general exercise for patients with diabetes.

This week we wrap up our nine-part series of Homerun Slides on An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes with information on Therapy for Type II Diabetes, Non-Insulin Therapy for Type II Diabetes, Concurrent Therapy….

If you find that your blood sugars often fluctuate from too high to too low (and vice versa), you’re on the blood sugar rollercoaster. To learn how to eliminate the extremes, you’ll have to do a little sleuthing on your own. Get out your blood glucose meter, and for a …

Glooko Connects Glucose Meters to iPhones for Tracking Diabetes Glooko is a cable that turns an iPhone into a log book which can generate different kind of reports. The special cable works on 7 of the most popular glucose monitors. Plug it into both devices and it downloads daily readings. …

FDA Panel Votes in Favor of Weight Loss Drug Qnexa An FDA advisory panel has voted 20-2 to recommend approval of the weight-loss drug Qnexa, but urged the agency to require a post-approval trial to monitor for cardiovascular side effects.

The Department of Health and Human Services is providing $10 million in fiscal year 2012 funding for the CDC’s National Diabetes Prevention Program. The NDPP is an initiative, authorized in 2010, which provides local communities with lifestyle change programs for preventing type 2 diabetes. “Expansion of the NDDP will allow …

Insulet and LifeScan have entered a partnership through which the latter’s OneTouch blood-glucose monitoring technology will be integrated into the former’s OmniPod Personal Diabetes Manager. They will develop a new PDM for the OmniPod tubeless Insulin pump system and expect to bring it to market in 2013. It will work …